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A B S T R A C T
BACKGROUND AND PURPOSE: Long-term surveillance of intracranial pressure (ICP) in neurological/neurosurgical patients
during ventilator weaning and early neurorehabilitation currently relies on clinical observation because neuroimaging is rarely
readily available. In this prospective study, multimodal neurosonography and pupillometry are evaluated for follow-up monitoring.
METHODS: Sonographic neuromonitoring was used to noninvasively examine patients’ ICP during weaning and early neu-
rorehabilitation. It allowed assessments of third ventricle width, possible midline shift, middle cerebral artery flow velocities,
and bilateral optic nerve sheath diameters. Quantitative pupillometry was used to determine pupil size and reactivity. Other
neuroimaging findings, spinal tap ICP measurements, and clinical follow-up data served as controls.
RESULTS: Seventeen patients—11 suffering from intracranial hemorrhage, four from encephalopathies, and two from ischemic
stroke—were examined for ICP changes by using neurosonography and pupillometry during a mean observation period of 21 days.
In total, 354 of 980 analyses (36.1%) yielded pathological results. In 15 of 17 patients (88.2%), pathological values were
found during follow-up without a clear clinical correlate. In two patients (11.8%), clinically relevant changes in ICP occurred
and were identified using neurosonography. Abnormal pupillometry findings displayed a high predictive value for absent clinical
improvement.
CONCLUSION: Multimodal neurosonography may be a noninvasive means for long-term ICP assessment, whereas pupillometry
may only detect rapid ICP changes during acute neurointensive care. The study also illustrates common pitfalls in neuromonitoring
in general, with large numbers of pathological albeit nonsignificant findings. Additional controlled studies should validate the
influence of detected subtle changes in ICP on neurological outcome.
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Introduction
Repetitive invasive measurements of intracranial pressure (ICP)
(such as measurements of intraparenchymal or intraventricu-
lar pressure obtained using a probe or ventricle drainage, or
lumbar puncture [LP]), and neuroimaging with magnetic reso-
nance imaging (MRI) and computed tomography (CT) are not
practicable in dedicated ventilator weaning and early neurore-
habilitation units (WENRUs), known in Germany as “neurore-
habilitation intensive care units.” The average hospital stay in
a WENRU is 44.6 days after initial acute treatment.1 It remains
unclear whether there is an evidence-based benefit of routine
This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and
reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
invasive ICP measurements, and long-term implantable moni-
toring devices have not yet progressed beyond the experimental
stage.2-5 Also, cerebral MRI or CT is not often readily avail-
able within the WENRU, which can lead to unnecessary and
sometimes risky transport of patients, especially ventilated pa-
tients, who lack clinical evidence for ICP elevations.6 Thus,
ICP surveillance is a diagnostic challenge in the WENRU,
especially in patients in whom pathological changes in ICP
may be relevant or have to be considered due to a particu-
lar brain injury such as following ventriculoperitoneal shunt
placement.
◦C 2020 The Authors. Journal of Neuroimaging published by Wiley Periodicals LLC on behalf of
American Society of Neuroimaging
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Noninvasive ICP assessment may be obtained at the pa-
tient’s bedside using transcranial and orbital sonography and
automated quantitative pupil measurement. Single sonographic
parameters, such as determination of third ventricle width, mid-
line shift (MLS), middle cerebral artery (MCA) flow velocities,
or optic nerve sheath diameters (ONSD), and pupil size and
reactivity, are established during the acute phase.7-11 Yet, the
combination of these different parameters may increase an ex-
amination’s sensitivity and specificity for changes in ICP and
thus lead to more efficient care for patients in the intensive care
setting.
The aim of this study was to evaluate the use of multimodal
neurosonography and pupillometry as a noninvasive real-time
bedside method in the long-term treatment of patients in the
WENRU. Any routine cerebral imaging or LP puncture with
pressure measurement as well as clinical follow-up can be used
for a reference study.
Methods
Participation Criteria and Data Collection
The present study was approved by the Ethics Committee at the
University of Regensburg (16-320-101) and was conducted in
accordance with the requirements of the Declaration of Helsinki
of the World Medical Association. Inclusion criteria limited par-
ticipants to adult neurorehabilitation patients; excluded were
patients without a sufficient temporal bone window and those
with diseases confined exclusively to the peripheral nervous
system. In addition, patients (or their legal guardians, if ap-
propriate) had to provide written consent before participation
in the study. Recruitment of patients usually took place 1 or
2 days after admission to the WENRU of the Department of
Neurology at Regensburg District Hospital.
The planned investigation period per patient lasted 4 weeks,
during which eight examinations of each patient were pur-
sued. Clinically relevant data, such as the patient’s sex, age,
underlying disease, and clinical follow-up, were recorded on
a data collection form. At each examination, transcranial B-
mode sonography (TCS), transcranial color-coded sonography
(TCCS), transorbital sonography (TOS), and pupillometry were
performed. If control reference examinations, such as CT or
invasive measurement of ICP (eg, LP), were performed in ad-
vance or as part of the regular treatment algorithm, the data
obtained were compared with the results of the neurosonogra-
phy and pupillometry studies. No additional CT or LP exami-
nations were performed solely for the study; such examinations
were added only if indicated by clinical criteria.
Technical Data of the Examination
TCS, TCCS, and TOS were performed using two color duplex
machines, each equipped with a sector and a high-frequency lin-
ear array transducer (Philips CX50 with S5-1 and L12-3 trans-
ducer, and GE Logiq 7 with S3 and L11 transducer). TCCS
and TCS were performed using a 1.5-3.5 MHz (GE Logiq 7 S3
transducer) and a 1-5 MHz sector (Philips S5-1 transducer) array
transducer with the patient supine. The width of the third ven-
tricle and any existing MLS were measured in the diencephalic
plane at the level of the epiphysis, as previously described.7,8
Pulsed-wave Doppler in TCCS was used to measure the flow
velocities of the proximal MCA. Relevant settings, such as pulse
repetition frequency, gain, and insonation angle, have already
been described in detail.10 Both systolic and end-diastolic max-
imum values were recorded to calculate the pulsatility index
(PI) according to Gosling and King.11 TOS was used to mea-
sure the ONSD using 3-11 MHz (GE Logiq L11 transducer) and
3-12 MHz (Philips L12-3 transducer) linear array transducers.
The ultrasound transmit power was applied according to the
ALARA (“as low as reasonably achievable”) principle (ie, me-
chanical index <.23), as previously described.12 For a reliable
assessment of the ONSD, three measurements were made for
each examination in order to calculate the mean value.
Pupillometry
Pupillometry was performed with the aid of the NeuroOptics R©
NPiTM-200 pupillometer, a hand-held optical reader used to
measure pupil size and reactivity, as previously described.13
The device combines an infrared camera, a signal processor,
and an LED light source. The automatically generated “Neu-
rological Pupil indexTM” (NPiTM) is based on an algorithm that
compares the measured value with a basic model of pupil
response to light and then grades the value on a scale from
0 to 5.
Control Examinations
Standard CT was performed using a Siemens Somatom Defi-
nition AS (Siemens Healthcare, Erlangen, Germany) CT and
software with 4-mm slice thickness to evaluate the width of the
third ventricle. The width was assessed on the axial image as the
distance between the inner boundaries of both ventricle walls
located in front of the pineal gland. The examination performed
as described, and an opening pressure greater than 20 cm H2O
and below 6 cm H2O was considered pathological.14
Statistical Analysis
The statistical evaluation included a descriptive analysis (in-
cluding number [n], percentage, range, means, and standard
deviation [SD]), median, quartiles (Q1 and Q3), interquartile
range (IQR), and Pearson’s correlation coefficient (R).
Results
Study Population and General Findings
During a median observation period of 21 days (Q1, 13 days;
Q3, 25 days; range 7-118 days), we examined 17 patients:
11 suffering from intracranial hemorrhage, four from en-
cephalopathies, and two from ischemic stroke. The median pa-
tient age was 62 years (Q1, 53 years; Q3, 72 years; range 32-80
years). Thirteen patients were males (76%). A median 8 exam-
inations per patient (Q1, 6 examinations; Q3, 8 examinations;
range 4-16 examinations) were performed, and 131 examina-
tions in all were included in our analysis. On average, bedside
examinations lasted 20-60 minutes depending on examination
conditions, which included completing some examinations in
patients with mechanical ventilation. The characteristics of pa-
tients are described in Table 1. An overview of the collected
parameters is presented in Table 2.
In a single patient, changes in ICP over 16 days highly
correlated with changes in third ventricle width and ONSD
(R = .93) (Table 3, patient 14; Figs 1-3). Pupillometry did not
provide sufficient evidence of pressure changes. In two of 17
patients (11.8%), we found clinically relevant changes in ICP
2 Journal of Neuroimaging Vol 00 No 0 xxxx 2020
Table 1. Characteristics of Patients
Characteristic N (%) or Median (IQR) Minimum Maximum Range
Total number 17
Age (years) 62 (53-72) 32 80 48
Sex—male 13 (76%)
Diagnosis
Intracranial hemorrhage 11 (65%)
Encephalopathy 4 (23%)
Ischemic stroke 2 (12%)
Shunt 3 (18%)
Number of measurements
Total number 131
Per patient 8 (6-8) 4 16 12
Follow up period per patient (days) 21 (13-25) 7 118 111
IQR, interquartile range; N, number.
Table 2. Median (IQR) Values, Minimums, Maximums, and Ranges of the Studied Parameters
Parameter Median (IQR) Minimum Maximum Range
Third ventricle (mm) 9.9 (8-12.2) 4.2 22.5 18.3
MLS (mm) 1.1 (.6-2.0) .0 5.2 5.2
ONSD l (mm) 5.2 (4.8-5.7) 4.0 6.7 2.7
ONSD r (mm) 5.2 (4.8-5.7) 3.5 6.6 3.1
PI MCA l 1.11 (.95-1.31) .64 2.16 1.52
PI MCA r 1.17 (.97-1.29) .64 1.96 1.32
NPiTM l 4.5 (4.1-4.7) 1.2 4.9 3.7
NPiTM r 4.4 (3.8-4.7) .7 4.9 4.2
IQR, interquartile range; l, left; MCA, middle cerebral artery; MLS, midline shift; NPiTM, neurological pupil index; ONSD, optic nerve sheath diameter; PI, pulsatility
index; r, right.
that could be detected by neurosonography and corresponding
therapeutic treatments, such as LP, shunt adjustment, and shunt
exchange (Table 3, patients 14 and 16). In 15 patients (88.2%),
pathological values without clinical correlates were found dur-
ing follow-up (Table 3). Of 980 values collected, 354 (36.1%)
were pathological, as will be explained in more detail below.
Clinical improvement or deterioration was extracted from the
weekly multidisciplinary team protocol.
Third Ventricle Width and MLS
In all patients, the third ventricle could be well visualized from
both sides. The median diameter of the third ventricle was
9.9 mm (Q1, 8 mm; Q3, 12.2 mm; range 4.2-22.5 mm; mean
± SD, 11.02 ± 4.33 mm). The average lateral difference was
.64 ± .64 mm (n = 262). If CT took place within 7 days of the
ultrasound examination and the patient did not display a clinical
change, a good accordance between both methods could be
shown (average difference: mean ± SD, .71 ± .45 mm; n = 12)
(Fig 1). In 82.4% of patients (Table 3), a deviation from the age-
dependent standard values of ventricle width (third ventricle
>4.8 ± 1.9 mm [age 40 ± 13 years] and >7.6 ± 2.1 mm [age
68 ± 8 years]) was found in the follow-up of the study.7 TCS
revealed a relevant MLS (MLS >3.5 mm) in 17.7% of patients
(Table 3), and this was monitored during follow-up (Table 3,
patient 6; Figs 4 and 5).20
MCA Flow Velocities
In all patients, MCA flow velocities were measured and the PI
was calculated. The median PI was 1.11 on the left side (Q1,
.95; Q3, 1.31; range .64-2.16; mean ± SD, 1.23 ± .34) and 1.17
on the right side (Q1, .97; Q3, 1.29; range .64-1.96; mean ± SD,
1.24 ± .35 mm). In 88.2% of patients, the PI was pathologically
increased (Table 3; PI 1.0).16
Optic Nerve Sheath Diameter
Intrarater reliability was high, as the three ONSD measure-
ments per examination showed an average standard deviation
of .19 mm (n = 702). The median ONSD was 5.2 mm on the
left side (Q1, 4.8 mm; Q3, 5.7 mm; range 4.0-6.7 mm; mean
± SD, 5.24 ± .61 mm) and 5.2 mm on the right side (Q1,
4.8 mm; Q3, 5.7 mm; range 3.5-6.6 mm; mean ± SD, 5.19 ±
.66 mm). The ONSD was pathologically increased unilaterally
in 23.5% of patients and bilaterally in 35.3% of patients (ONSD
>5.8 mm).9,12,17
Results of Pupillometry
Pupillometry could be performed properly in all but one patient
who was restlessness. The median NPiTM was 4.5 on the left side
(Q1, 4.1; Q3, 4.7; range 1.2-4.9; mean ± SD, 4.2 ± .7) and 4.4
on the right side (Q1, 3.8; Q3, 4.7; range .7-4.9; mean ± SD,
3.9 ± 1.1). In 29.4% of patients, an abnormal pupil reaction was
found (NPiTM <3.0 and/or a lateral difference in NPiTM .7,
Table 3).13
Discussion
In this study, we demonstrated the utility of multimodal neu-
rosonography to characterize short- and long-term ICP changes
during early neurorehabilitation, including in patients who were
being weaned from mechanical ventilation. To the best of our
knowledge, this is the first study performed to investigate the
noninvasive long-term follow-up of ICP in a WENRU by using
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Fig 1. A 56-year-old female patient with a ventriculoperitoneal shunt following subarachnoid hemorrhage from a right posterior inferior
cerebellar artery aneurysm and hydrocephalus occlusus, resulting in tetraparesis and severe neuropsychological defects. (A) CT at admission
to the weaning and early neurorehabilitation unit showing a significantly dilated third ventricle (14.7 mm). (B) Transcranial B-mode sonography
(TCS) on day 6 after admission: an increase in ventricle width to 15.6 mm. (C) TCS follow-up after 13 days of therapy (LP and shunting): width of
third ventricle within normal parameters (7.3 mm). After therapy, the patient exhibited cognitive and motor improvements. Transorbital B-mode
ultrasonography in the same patient: D (left) and F (right). Transorbital measurement of the ONSD day 6 after admission shows pathological
values (5.9 mm, left eye; 6.0 mm, right eye). E (left) and G (right) Follow-up after 13 days of therapy (LP and shunting): width of the ONSD
within normal parameters (4.4 mm, left eye; 5.0 mm right eye).
multimodal neurosonography and pupillometry. In a WENRU,
as opposed to an acute neurology and neurosurgery intensive
care unit, sudden and acute changes in ICP are rare events,
invasive ICP measurements are absent, and cCT is frequently
not readily available.
Sonographic measurement of the third ventricle is a well-
established method.7-9 In all 131 TCS examinations, we were
able to identify and measure the third ventricle. In line with
the clinical findings, elevations in ICP with concurrent changes
in third ventricle width could be measured and, following a
successful ICP-lowering therapy, decreases in ICP could be
monitored—a finding in agreement with the report by Kiphuth
et al.18 Minimal deviations can be explained by (1) a time
interval between the CT and TCS examinations and (2) the
Siepen et al: Neurosonography in Neurorehabilitative Intensive Care 5
Fig 2. Changes in the width of the third ventricle and the ONSD in the same patient over a period of 16 days.
higher resolution of TCS compared with CT. However, these
differences were less than 1 mm and therefore not clinically
significant.
Bedside TCS for an MLS is of high relevance especially
in acute neurology, but also in the follow-up of patients with
chronic intracranial pathologies; it displays high agreement
with CT but can be repeated numerous times.8,19-21 When an
MLS was present, we were able to detect it and follow its course
using TCCS in good accordance with findings on CT. Sono-
graphic MLS evaluation is not only suitable for the acute stage
of brain injury but also for long-term observation during the
later course of the disease.
Blood flow analysis is an important adjunct for sonographic
ICP measurements. Bellner et al were able to show a strong
correlation between ICP measured with an intraventricular
catheter and with the PI of the MCA.22 Based on this assump-
tion, we were also able to show a correlation between ICP
and the PI of the MCA. Fortunately, none of the patients suf-
fered from ICP elevation to the extent that cerebral blood flow
was severely compromised, which is the normally strength of
this technique. However, we also found no direct (time-related)
correlation between the PI and the other measurements (third
ventricle width, MLS, ONSD, or NPiTM).
ONSD measurement is becoming increasingly popular as a
noninvasive method of ICP evaluation in a variety of neuro-
logical diseases.12,17,23-28 The reliability of sonographic ONSD
measurements has been consistently rated according to pub-
lished data in healthy individuals, and although there was no
blinded review in our study, the supervising experienced neu-
rologists (FS and DB) assured high quality.29-31 An ONSD of
>5.8 mm correlates well with an elevated ICP, and both in-
creases and decreases in ICP are immediately measurable in
the ONSD.17,32 Using TOS, we detected pathological changes
in the ONSD and measured increases or decreases in the di-
ameter during follow-up. However, a formerly elevated ICP of
>45 mmHg (ie, acute hydrocephalus from acute severe sub-
arachnoid hemorrhage) can lead to structural changes within
the ONSD and may lead to false-positive findings, stressing
the importance for conducting a baseline TOS examination on
patient admission.33
Another method of ICP diagnostic is pupillometry. Man-
ual pupil measurements (“swinging flash light”) show only a
low interrater reliability, are important in acute neurology, and
can be objectified with the aid of a pupillometer.15,34 Using
pupillometry, Chen et al were able to demonstrate a correla-
tion between decreasing pupil response and increasing ICP,
which proved to be a useful method for early assessment of
patients with elevated ICP.35 In patients during WENRU, we
were able to detect changes in the ICP by using sonography
and clinical findings, whereas no such correlation was apparent
(or remained unnoticed) using pupillometry. This observation
may be due to the small number of patients in our study, whose
only moderately increased ICP occurred over a long period of
time and had little influence on the sympathetic or parasympa-
thetic nervous system, or to the use of cholinergic drugs, such as
opiates or barbiturates. However, we did find a high correlation
between an abnormal pupil response and the absence of clin-
ical improvement: no clinical improvement (defined by medi-
cal and rehabilitative [physiotherapy and occupational therapy]
follow-up) was found in any patients with a pathological NPiTM
(n = 5).
Clinical Relevance of Subclinical ICP Elevation
In our study, we detected subtle elevations in ICP without
any apparent clinical deterioration. Current research on the
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Fig 3. Correlation between the width of the third ventricle measured by transcranial sonography and the ONSD in the same patient.
Fig 4. A 32-year-old female patient with craniectomy following space-occupying media infarction on the right side. (A-C) Course of midline
shift (MLS) from the left to the right hemisphere. (A) Transcranial B-mode sonography (TCS) on day 4 after admission to the weaning and
early neurorehabilitation unit: MLS of 1.6 mm to the left and marked right-sided hemorrhagic transformation. (B) TCS follow-up on day 14 after
admission: decrease of the infarct with a mild nonsignificant MLS of 4.1 mm now to the right. (C) CT on day 25 after admission confirms a
further decreasing MLS to the right.
perivascular spaces and brain interstitial fluid proposes a link
between the microcirculation and brain detoxication.36,37 Thus,
any changes in ICP may influence long-term outcome in brain
repair. Noninvasive ICP measurements have the potential to
guide critically ill neurological patients through successful neu-
rorehabilitation.
Strengths and Limitations of the Study
Sonography remains an examiner-dependent technique, and
TCCS, not TCS, is dependent on the presence of a sufficient
temporal bone window (especially in elderly women) and is thus
subject to related inaccuracies. Nevertheless, bone defects due
to trepanation allow for high-quality brain scans and should be
exploited more frequently in early neurorehabilitation surveil-
lance strategies. Standardized protocols, teaching efforts, and
the use of an archive system for second opinions are possible
solutions. Another limitation is the use of reference values in
patients with severe brain injury and following prolonged acute
intensive care medicine. These patients often show abnormal
baseline values, and neurosonographic monitoring should be
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Fig 5. Course of midline shift from the left to the right hemisphere measured by transcranial sonography of the same patient.
normalized in timely association with the latest cCT and/or
ICP measurements from the transferring acute clinic. Yet, clin-
ical evaluation of patients with severe brain injury and pro-
longed coma also has limitations. Indices for a standardized
assessment, such as the Barthel Index or the Extended Barthel
Index, proved to be too imprecise to detect rapid ICP changes
at an early stage and were therefore not used by us as an ex-
amination method. The strength of this study is the use of pure
bedside and noninvasive diagnostics technique with no appar-
ent side effects that are widely available in neurorehabilita-
tion as opposed to cCT, MRI, or even direct ICP measure-
ments. Patients with large bone defects are prime candidates
for this kind of follow-up. A relevant limitation is our small
and heterogeneous patient group and absent blinding; how-
ever, the investigator was not part of the treating team. Future
large observational studies should be conducted to confirm our
findings.
Conclusions
Our results show that multimodal neurosonography is suitable
for noninvasive, repetitive assessment of ICP, especially in a
WENRU, and can be a useful alternative to CT and LP in de-
tecting complications from raised ICP. In addition, multimodal
neurosonography may provide better insight into various as-
pects of the pathophysiology of neurological diseases. Pupil-
lometry currently has greater significance when used to identify
rapidly occurring ICP changes; in the future, it may serve as
a predictive marker for the patient’s clinical course. By com-
bining different methods of measurement, changes in pressure
could be detected more specifically, and the sensitivity of single
measuring methods could be increased. Especially in cases of
complex brain diseases, normal values should not be assessed
as absolutes, but rather as comparative values within individ-
uals during follow-up, so that complications can be detected
earlier and therapy can be initiated. Therefore, we recommend
that early validation of multimodal neurosonography using es-
tablished imaging methods should be made upon WENRU
admission to establish a baseline profile.
Outlook
Additional studies in larger numbers of patients in the WENRU
are needed to determine whether multimodal sonography can
serve as the doorkeeper for out-of-WENRU neuroimaging pro-
cedures and therapies. Further objectives should address mod-
erate long- and short-term management of the ICP guided by
sonographic neuromonitoring and their influence on long-term
outcome in neurorehabilitation.
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